ES2059501T3 - Aminoacidos utiles en trastornos hepaticos. - Google Patents

Aminoacidos utiles en trastornos hepaticos.

Info

Publication number
ES2059501T3
ES2059501T3 ES88301678T ES88301678T ES2059501T3 ES 2059501 T3 ES2059501 T3 ES 2059501T3 ES 88301678 T ES88301678 T ES 88301678T ES 88301678 T ES88301678 T ES 88301678T ES 2059501 T3 ES2059501 T3 ES 2059501T3
Authority
ES
Spain
Prior art keywords
amino acids
hepatic disorders
useful amino
disorders
alamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88301678T
Other languages
English (en)
Other versions
ES2059501T5 (es
Inventor
Hisanori Masaki
Kunio Torii
Tomio Suda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12606501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2059501(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of ES2059501T3 publication Critical patent/ES2059501T3/es
Application granted granted Critical
Publication of ES2059501T5 publication Critical patent/ES2059501T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION ES UN MEDICAMENTE QUE CONTIENE L - ALAMINA O L GLUTAMINA BIEN SEPARADAMENTE O JUNTAS LAS CUALES PUEDEN SER UTILIZADAS EN LA TERAPIA O EN LA PREVENCION DE DESORDENES HEPATICOS PARTICULARMENTE CUANDO ESTOS DESORDENES SON DEBIDOS AL ABUSO DE ALCOHOL. LA L - ALAMINA Y L GLUTAMINA PUEDEN SER PRESENTADOS EN RADIOS MOLARES DE 1:0,1 A 1:10.
ES88301678T 1988-02-24 1988-02-26 Aminoacidos utiles en trastornos hepaticos. Expired - Lifetime ES2059501T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63041368A JPH01216924A (ja) 1988-02-24 1988-02-24 肝障害治療剤

Publications (2)

Publication Number Publication Date
ES2059501T3 true ES2059501T3 (es) 1994-11-16
ES2059501T5 ES2059501T5 (es) 1997-06-16

Family

ID=12606501

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88301678T Expired - Lifetime ES2059501T5 (es) 1988-02-24 1988-02-26 Aminoacidos utiles en trastornos hepaticos.

Country Status (6)

Country Link
US (1) US4987123A (es)
EP (1) EP0329879B2 (es)
JP (1) JPH01216924A (es)
KR (1) KR960008651B1 (es)
DE (1) DE3883743T3 (es)
ES (1) ES2059501T5 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189016A (en) * 1990-05-18 1993-02-23 Clintec Nutrition Co. Nutrient compositions containing peptides and method for administering the same
WO1992004023A1 (en) * 1990-09-10 1992-03-19 Shug Austin L Composition and method for protecting the heart during reperfusion
JP3127484B2 (ja) 1991-02-28 2001-01-22 味の素株式会社 肝炎治療薬
GB9121467D0 (en) * 1991-10-10 1991-11-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
JP3168669B2 (ja) * 1992-02-26 2001-05-21 味の素株式会社 肝再生促進剤
AU6232794A (en) * 1993-01-29 1994-08-15 Brigham And Women's Hospital The use of nitric oxide-delivering compounds for the treatment or prevention of alcoholic liver injury
ES2196053T3 (es) * 1994-01-11 2003-12-16 Stichting Zofia Procedimiento para el tratamiento de trastornos del cuerpo humano o animal mediante la administracion de aminoacidos.
US5561111A (en) * 1994-12-23 1996-10-01 The University Of Virginia Patent Foundation Stable glutamine derivatives for oral and intravenous rehydration and nutrition therapy
US6649746B1 (en) 1999-05-07 2003-11-18 University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
GB0114419D0 (en) * 2001-06-13 2001-08-08 Mars Uk Ltd Health food
SE0201713D0 (sv) 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III
TWI351278B (en) * 2002-03-01 2011-11-01 Nisshin Pharma Inc Agent for preventing and treating of liver disease
JP4559380B2 (ja) * 2002-03-01 2010-10-06 日清ファルマ株式会社 肝疾患治療剤
US20060089412A1 (en) * 2004-10-18 2006-04-27 Ajinomoto Co. Inc. Pharmaceutical composition for the treatment of non-alcoholic fatty liver disease
WO2007059031A2 (en) * 2005-11-10 2007-05-24 Massachusetts Institute Of Technology Methods and compositions for raising levels and release of gamma aminobutyric acid
JP5642922B2 (ja) * 2007-04-24 2014-12-17 サントリーホールディングス株式会社 複数の肝障害マーカーを指標とする肝障害の評価方法
JP2012041324A (ja) * 2010-08-23 2012-03-01 Ajinomoto Co Inc 白金含有薬剤投与による肝機能低下の抑制剤
CN103445175B (zh) * 2013-09-17 2014-10-08 深圳万和制药有限公司 具有解酒保肝作用的组合物
JP2016086715A (ja) * 2014-10-31 2016-05-23 アサヒグループホールディングス株式会社 ニンジン由来成分含有飲食品
MX2017016479A (es) 2015-06-19 2018-08-15 Chigurupati Harsha Composicion de bebidas sinergicas.
WO2017216813A1 (en) 2016-06-18 2017-12-21 Chigurupati Harsha Composition to reduce dna and hepatic damage and to enhance repair thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR762M (es) * 1960-08-31 1961-08-28
FR2372626A1 (fr) * 1976-12-02 1978-06-30 Sertog Compositions therapeutiques a base d'un extrait de plantes et d'amino-acides
JPS6150917A (ja) * 1984-08-20 1986-03-13 Ajinomoto Co Inc 抗アルコ−ル性肝障害組成物
US4870056A (en) * 1986-01-23 1989-09-26 Regents Of The University Of Minnesota Acylated cyanamide composition
JPH0420409A (ja) * 1990-05-14 1992-01-24 Daifuku Co Ltd ストレージ可能なコンベヤ装置

Also Published As

Publication number Publication date
EP0329879A1 (en) 1989-08-30
KR960008651B1 (ko) 1996-06-28
JPH01216924A (ja) 1989-08-30
EP0329879B2 (en) 1997-04-16
DE3883743T3 (de) 1997-12-04
EP0329879B1 (en) 1993-09-01
KR890012644A (ko) 1989-09-18
DE3883743T2 (de) 1994-03-17
DE3883743D1 (de) 1993-10-07
ES2059501T5 (es) 1997-06-16
US4987123A (en) 1991-01-22

Similar Documents

Publication Publication Date Title
ES2059501T3 (es) Aminoacidos utiles en trastornos hepaticos.
IL99769A0 (en) Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
TW225534B (es)
IL96790A0 (en) A-nor-steroid-3-carboxylic acid derivatives
DE69627153D1 (de) Zusammensetzungen zur erzielung von analgesie und zur hemmung der progression neuropathischer schmerzerkrankungen
BR9808875A (pt) Combinação de analgésicos
ES2058346T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
ES2032465T3 (es) Variantes de la hirudina, su utilizacion y su preparacion.
HUP9802206A1 (hu) Thalidomid intravénás adagolási formája immunológiai megbetegedések gyógyításához
EP0426489A3 (en) Hydrogen peroxide destroying compositions and methods of using same
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
EP0318233A3 (en) Improvements in or relating to serotonin and norepinephrine uptake inhibitors
US5011841B1 (en) Treatment of depression
MY106615A (en) Stabilized leukocyte-interferons.
EP0405120A3 (en) Composition for permanent deformation of hair
BR9007714A (pt) Composicoes do tipo azeotropico de di-cloro-penta-fluor-propano e 1,2-di-cloro-etileno
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
GB8812331D0 (en) Perfumed aqueous compositions
ITMI931371A1 (it) Procedimento per la preparazione dell'erdosteina
KR910011390U (ko) 브레이크 배력장치의 키 부재의 빠짐방지장치
FR2572274B1 (fr) Clou d'osteosynthese.
DE59301633D1 (de) Konzentrat zur herstellung von metallbeizmitteln

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 329879

Country of ref document: ES